Help prevent RSV pneumonia in healthy infants. Seattle Children’s is recruiting infants for a phase 3 clinical research study looking at an investigational medication (monoclonal antibody) for prevention of RSV lower respiratory tract infection. Infants may be eligible if they were born on or after May 1, 2019, reached gestational age of 35 weeks or later and are healthy with no known history of RSV infection or lung disease. Infants would be in the study for about one year and six months, and would come to the Seattle Children’s research center for at least six visits. Infants would be closely monitored for respiratory illness throughout the study.

The MELODY study is a randomized, double-blind, placebo-controlled clinical trial. It will include about 3,000 babies globally. Dr. Janet Englund of Seattle Children’s is the principal investigator.

If you would like to learn more about the study or have a patient who is interested, please contact or call 206-884-1100.

Other Clinical Trials Recruitment at Seattle Children’s

Recruiting Young Adults for Diabetes Heart Health Study

Seattle Children’s Diabetes Research team is recruiting young adults ages 18 to 24 who do not have diabetes for a research study to help us learn more about heart health in young adults with type 1 and type 2 diabetes. Learn more.

Recruiting Children With ADHD for Research Study

Dr. Anne Arnett is recruiting children ages 7 to 11 with a diagnosis of ADHD (with or without hyperactivity) to participate in a single, three-hour visit to University of Washington’s Center on Human Development and Disability. Participation includes cognitive and academic testing, with provision of test results via written report. The visit also involves an EEG, a noninvasive way to measure brain activity, and includes watching videos, playing games, and listening to sounds. Families earn $40, prizes and parking reimbursement. Call 206-616-6929 or email Dr. Arnett at to learn more.